This new diabetes pill burns fat without the downsides of Ozempic

Article excerpt

Researchers have developed an experimental pill that tackles diabetes and obesity through a novel mechanism: activating metabolism in skeletal muscle rather than suppressing appetite like Ozempic does. The drug lowers blood sugar and burns fat while preserving muscle mass, a potential advantage over GLP-1 drugs that can cause muscle loss. Early clinical data shows the treatment is safe and well tolerated, offering a fundamentally different approach to metabolic disease.